(19)
(11) EP 1 087 761 A2

(12)

(88) Date of publication A3:
01.02.2001

(43) Date of publication:
04.04.2001 Bulletin 2001/14

(21) Application number: 00920435.5

(22) Date of filing: 14.02.2000
(51) International Patent Classification (IPC)7: A61K 31/192, A61K 31/4035, A61K 31/53, A61K 31/437, A61K 31/426, A61K 31/423, A61K 31/502, A61K 31/195, A61K 31/4409, A61K 31/4406, A61P 25/00, A61P 25/28, A61P 9/10, C07D 253/04
(86) International application number:
PCT/EP0001/204
(87) International publication number:
WO 0050/017 (31.08.2000 Gazette 2000/35)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 25.02.1999 EP 99103723

(71) Applicant: Bayer Aktiengesellschaft
51368 Leverkusen (DE)

(72) Inventors:
  • HINZ, Volker
    D-50670 Köln (DE)
  • HANING, Helmut
    D-42115 Wuppertal (DE)
  • RIEDL, Bernd
    D-42329 Wuppertal (DE)
  • HENNING, Rolf
    D-42113 Wuppertal (DE)
  • STOLLE, Andreas
    Milford, CT 06460 (US)
  • KELDENICH, Jörg
    D-42113 Wuppertal (DE)
  • BRÜCK, Antje
    D-51375 Leverkusen (DE)
  • SCHUHMACHER, Joachim
    D-42109 Wuppertal (DE)

   


(54) USE OF SUBSTITUTED 4-BIARYLBUTYRIC AND 5-BIARYLPENTANOIC ACID DERIVATIVES FOR THE TREATMENT OF CEREBRAL DISEASES